A prospective randomized controlled trial of the effects of Vitamin D supplementation on cardiovascular disease risk

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Gepner, Adam D ^a   Ramamurthy, Rekha ^a   Krueger, Diane C ^a   Korcarz, Claudia E ^a   Binkley, Neil ^a   Stein, James H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; COLECALCIFEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CELL FUNCTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VASODILATATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; VASODILATION; VITAMIN D;

EID: 84860641908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036617     Document Type: Article

References (46)

1. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
2. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR, (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30: 771-777.
3. Autier P, Gandini S, (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167: 1730-1737.
4. Lavie CJ, Lee JH, Milani RV, (2011) Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol 58: 1547-1556.
5. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, et al. (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106: 963-968.
6. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF, (2008) Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52: 1949-1956.
7. Giovannucci E, Liu Y, Hollis BW, Rimm EB, (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180.
8. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
9. Reddy VS, Good M, Howard PA, Vacek JL, (2010) Role of vitamin D in cardiovascular health. Am J Cardiol 106: 798-805.
10. Mheid IA, Patel R, Murrow J, Morris A, Rahman A, et al. (2011) Vitamin d status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58: 186-192.
11. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, et al. (1995) Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8: 894-901.
12. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R, (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19: 559-563.
13. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, et al. (2006) Reduced vitamin D in acute stroke. Stroke 37: 243-245.
14. Vita JA, Keaney JF Jr, (2002) Endothelial function: a barometer for cardiovascular risk? Circulation 106: 640-642.
15. Geleijnse JM, (2010) Vitamin D and the Prevention of Hypertension and Cardiovascular Diseases: A Review of the Current Evidence. Am J Hypertens 24: 253-262.
16. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, et al. (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27: 2588-2605.
17. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265.
18. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, et al. (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115: 846-854 (Erratum in: Circulation. 2007 May 15: 115 (19): e466.
19. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD, (2008) Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25: 320-325.
20. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, et al. (2008) Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 52: 847-855.
21. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ, (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204-210.
22. Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, et al. (2008) Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol 52: 569-576.
23. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, et al. (2010) Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 55: 1988-1995.
24. Korcarz CE, Gepner AD, Peppard PE, Young TB, Stein JH, (2010) The effects of sleep-disordered breathing on arterial stiffness are modulated by age. Sleep 33: 1081-1085.
25. Binkley N, Drezner MK, Hollis BW, (2006) Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation. Clin Chem 52: 2124-2125.
26. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK, (2006) HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52: 1120-1126.
27. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR, (2011) 25-hydroxyvitamin d deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57: 63-69.
28. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, et al. (2010) The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53: 2112-2119.
29. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, et al. (2010) A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 95: 4584-4591.
30. Andrade J, Er L, Ignaszewski A, Levin A, (2008) Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness. Clin J Am Soc Nephrol 3: 1800-1806.
31. Sepulveda JL, Mehta JL, (2005) C-reactive protein and cardiovascular disease: a critical appraisal. Curr Opin Cardiol 20: 407-416.
32. Amer M, Qayyum R, (2012) Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 109: 226-230.
33. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, et al. (2001) 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167: 4974-4980.
34. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU, (1997) 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 272: H1751-H1758.
35. Inoue M, Wakasugi M, Wakao R, Gan N, Tawata M, et al. (1992) A synthetic analogue of vitamin D3, 22-oxa-1,25-dihydroxy-vitamin D3, stimulates the production of prostacyclin by vascular tissues. Life Sci 51: 1105-1112.
36. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, et al. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238.
37. Shapses SA, Manson JE, (2011) Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. JAMA 305: 2565-2566.
38. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159-1165.
39. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME, (2010) The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail 3: 195-201.
40. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, et al. (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83: 754-759.
41. Oliver JJ, Webb DJ, (2003) Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23: 554-566.
42. Vieth R, (2006) Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 136: 1117-1122.
43. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, et al. (2010) The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. J Clin Endocrinol Metab 96: 53-58.
44. Cannell JJ, Hollis BW, Zasloff M, Heaney RP, (2008) Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 9: 107-118.
45. Vieth R, (2007) Vitamin D toxicity, policy, and science. J Bone Miner Res 22 (Suppl 2): V64-V68.
46. O'Keefe JH, Lavie CJ, Holick MF, (2011) Vitamin D supplementation for cardiovascular disease prevention. JAMA 306: 1546-1547; author reply 1547-1548.